|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PARRIS N. GLENDENING, Governor Ch. 565
|
|
|
|
|
|
|
|
|
|
(II) $20 FOR A PRESCRIPTION FOR A PREFERRED BRAND NAME
DRUG; AND
(III) $35 FOR A PRESCRIPTION FOR A NONPREFERRED BRAND NAME
DRUG; AND
(5) LIMIT THE TOTAL ANNUAL BENEFIT TO $1,000 PER INDIVIDUAL.
(B) THE PLAN MAY INCLUDE A RESTRICTED FORMULARY OF EXPERIMENTAL
DRUGS NOT APPROVED BY THE FEDERAL FOOD AND DRUG ADMINISTRATION FOR
GENERAL USE THAT WILL NOT BE REIMBURSED.
(C) (1) DURING THE FIRST 180 DAYS OF THE OPERATION OF THE PLAN, THE
CARRIER MAY ENROLL ONLY ELIGIBLE INDIVIDUALS WHO WERE:
(I) ENROLLED IN MEDICARE PLUS CHOICE MANAGED CARE
PROGRAMS IN MEDICALLY UNDERSERVED COUNTIES OR PORTIONS OF COUNTIES ON
OR BEFORE DECEMBER 31. 1999; AND
(II) AFTER DECEMBER 31,1999, CEASED TO BE ENROLLED IN THOSE
PLANS.
(2) ON AND AFTER THE 1B1ST DAY OF THE OPERATION OF THE PLAN,
THE CARRIER MAY ENROLL ANY ELIGIBLE INDIVIDUAL.
(3) THE CARRIER SHALL WORK WITH THE SECRETARY AND THE
MARYLAND DEPARTMENT OF AGING TO PROVIDE NOTICE, THROUGH THE WRITTEN
AND ELECTRONIC MEDIA AND OTHER MEANS, TO THE ELIGIBLE INDIVIDUALS
ELIGIBLE FOR ENROLLMENT IN THE FIRST 180 DAYS OF THE OPERATION OF THE
PLAN, OF THE AVAILABILITY OF THE PLAN AND OF THE ENROLLMENT PREFERENCE
TO BE GRANTED.
15-604.
(A) THERE IS A SHORT-TERM PRESCRIPTION DRUG SUBSIDY PLAN FUND.
(B) THE FUND CONTAINS THE ASSESSMENT AGAINST CARRIERS MADE UNDER
§ 15-606(C) OF THE INSURANCE ARTICLE.
(C) THE FUND IS A SPECIAL, CONTINUING, NONLAPSING FUND THAT IS NOT
SUBJECT TO § 7-302 OF THE STATE FINANCE AND PROCUREMENT ARTICLE.
(D) THE TREASURER SHALL SEPARATELY HOLD, AND THE COMPTROLLER
SHALL ACCOUNT, FOR THE FUND.
(E) (1) THE FUND SHALL BE INVESTED AND REINVESTED IN THE SAME
MANNER AS OTHER STATE FUNDS.
(2) ANY INVESTMENT EARNINGS SHALL BE RETAINED TO THE CREDIT
OF THE FUND.
(F) THE FUND SHALL BE SUBJECT TO AN AUDIT BY THE OFFICE OF
LEGISLATIVE AUDITS, AS PROVIDED IN § 2-1220 OF THE STATE GOVERNMENT
ARTICLE.
|
|
|
|
|
|
|
|
|
|
- 3001 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
